Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in MGNX — Macrogenics Inc

CIK 1692234 Seattle, WA
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$287,884
+$283,714 QoQ
Shares Held
62,313
+4218.3% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. MGNX ranks #174 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in MGNX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $287,884 62,313
2026-03-31 $4,170 1,443
2025-12-31 $2,055 1,277
2025-09-30 $82,495 49,105
2025-06-30 $59,971 49,564
2025-03-31 $2,049 1,614
2024-12-31 $5,154 1,586
2024-09-30 $53,015 16,114
2024-06-30 $78,157 18,390
2024-03-31 $234,901 15,958
2023-12-31 $147,590 15,342
2023-09-30 $135,078 28,987
2023-06-30 $184,419 34,471
2023-03-31 $144,575 20,164
2022-12-31 $256,858 38,280
2022-09-30 $262,544 75,880
2022-06-30 $87,261 29,580
2022-03-31 $129,330 14,680
2021-12-31 $235,614 14,680
2021-09-30 $307,399 14,680
2021-06-30 $1,626,318 60,548
2021-03-31 $3,102,029 97,395
2020-12-31 $1,561,932 68,326
2020-09-30 $2,213,394 87,868
2020-06-30 $1,751,029 62,716
2020-03-31 $317,014 54,470